MedPath
HSA Approval

CURAM FILM-COATED TABLET 625 mg

SIN10599P

CURAM FILM-COATED TABLET 625 mg

CURAM FILM-COATED TABLET 625 mg

December 31, 1998

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01CR02

amoxicillin and beta-lactamase inhibitor

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

SANDOZ GMBH

Active Ingredients

POTASSIUM CLAVULANATE EQV CLAVULANIC ACID

125 mg

Clavulanic acid

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

500 mg

Amoxicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CURAM FILM-COATED TABLET 625 mg - HSA Approval | MedPath